"/>

    India's pharma sector pins hope after China exempts import tariffs for 28 drugs
    Source: Xinhua   2018-05-08 21:04:12

    By Pankaj Yadav

    NEW DELHI, May 8 (Xinhua) -- India is committed to promoting its pharmaceutical exports to untapped markets, including China, said Indian companies at a three-day international exhibition of pharma and healthcare (iPHEX) which kicked off on Tuesday.

    The exhibition has been organized by the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) in which more than 650 delegates from 130 countries and regions are participating.

    China has exempted import tariffs for 28 drugs, including all cancer drugs, from May 1, which was seen as a good news for India's pharmaceutical industry and medicine export to China, as it would help in reducing trade imbalance between China and India in the future.

    Leading Indian companies participating in Tuesday's event hailed and welcomed China's move saying it would benefit both sides, as it would address India's trade imbalance and also China would get quality drugs at much lesser prices.

    Dr Dinesh Dua, the chief executive officer (CEO) of Nectar Lifesciences Ltd. based in Chandigarh city in northern India, said that he expected China, which is the second largest drugs market after the United States, would benefit a lot as Indian drugs prices are excellent.

    Indian companies can do excellent business in the next years in China, which augurs really well for the Indian pharmaceutical companies, he added.

    Besides cancer drugs, Due said, other drugs which India can export to China include "monoclonol antibodies" and also "chemotherapeutic agents" which Indian companies are very successfully making for other countries at a fraction of cost which innovators are making available.

    "The multinational companies (MNCs) are making available these generic drugs in China as local generic companies can't make them. India has proven to the rest of the world, so China will too greatly benefit by Indian pricing and quality of drugs coming in at a fraction of cost of the MNCs," Dua said.

    According to official figures, during the 11 months from April 2017 to January 2018, the pharma exports were recorded at 10.76 billion U.S. dollars in India. The exports are expected to grow by 30 percent over the next three years to reach 20 billion U.S.dollars by 2020.

    Indian pharmaceutical sector is estimated to account for 3.1-3.6 percent of the global pharmaceutical industry in value terms, and 10 percent in volume terms.

    India is believed to be the largest provider of generic drugs globally with the Indian generics accounting for 20 percent of global exports in terms of volume.

    In India cost of production of pharmaceutical items is nearly 33 percent lower than that of the United States, labor costs are 50-55 percent cheaper than in western countries. And, also the cost of setting up a production plant in India is 40 percent lower than in the West.

    Editor: ZX
    Related News
    Xinhuanet

    India's pharma sector pins hope after China exempts import tariffs for 28 drugs

    Source: Xinhua 2018-05-08 21:04:12
    [Editor: huaxia]

    By Pankaj Yadav

    NEW DELHI, May 8 (Xinhua) -- India is committed to promoting its pharmaceutical exports to untapped markets, including China, said Indian companies at a three-day international exhibition of pharma and healthcare (iPHEX) which kicked off on Tuesday.

    The exhibition has been organized by the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) in which more than 650 delegates from 130 countries and regions are participating.

    China has exempted import tariffs for 28 drugs, including all cancer drugs, from May 1, which was seen as a good news for India's pharmaceutical industry and medicine export to China, as it would help in reducing trade imbalance between China and India in the future.

    Leading Indian companies participating in Tuesday's event hailed and welcomed China's move saying it would benefit both sides, as it would address India's trade imbalance and also China would get quality drugs at much lesser prices.

    Dr Dinesh Dua, the chief executive officer (CEO) of Nectar Lifesciences Ltd. based in Chandigarh city in northern India, said that he expected China, which is the second largest drugs market after the United States, would benefit a lot as Indian drugs prices are excellent.

    Indian companies can do excellent business in the next years in China, which augurs really well for the Indian pharmaceutical companies, he added.

    Besides cancer drugs, Due said, other drugs which India can export to China include "monoclonol antibodies" and also "chemotherapeutic agents" which Indian companies are very successfully making for other countries at a fraction of cost which innovators are making available.

    "The multinational companies (MNCs) are making available these generic drugs in China as local generic companies can't make them. India has proven to the rest of the world, so China will too greatly benefit by Indian pricing and quality of drugs coming in at a fraction of cost of the MNCs," Dua said.

    According to official figures, during the 11 months from April 2017 to January 2018, the pharma exports were recorded at 10.76 billion U.S. dollars in India. The exports are expected to grow by 30 percent over the next three years to reach 20 billion U.S.dollars by 2020.

    Indian pharmaceutical sector is estimated to account for 3.1-3.6 percent of the global pharmaceutical industry in value terms, and 10 percent in volume terms.

    India is believed to be the largest provider of generic drugs globally with the Indian generics accounting for 20 percent of global exports in terms of volume.

    In India cost of production of pharmaceutical items is nearly 33 percent lower than that of the United States, labor costs are 50-55 percent cheaper than in western countries. And, also the cost of setting up a production plant in India is 40 percent lower than in the West.

    [Editor: huaxia]
    010020070750000000000000011100001371645361
    主站蜘蛛池模板: 国产欧美va欧美va香蕉在| 成人午夜免费视频免费看| 亚洲视频在线观看地址| 中文字幕第12页| 目中无人在线观看免费高清完整电影| 国产欧美日韩综合精品一区二区| www.欧美色图| 日本国产成人精品视频| 亚洲国产欧美日韩精品一区二区三区 | 国产成人AAAAA级毛片| 三极片在线观看| 最新版天堂资源8网| 啊灬嗯灬快点啊灬轻点灬啊灬| 中文字幕你懂的| 大香人蕉免费视频75| 中文无遮挡h肉视频在线观看| 欧洲一区二区三区在线观看 | 800av在线播放| 在线视频你懂的国产福利| 亚洲一级毛片免观看| 男人j进女人p免费视频| 国产中文字幕免费| 四虎永久在线观看视频精品| 成年美女黄网站小视频| 亚洲av永久无码精品网站| 热久久综合这里只有精品电影| 卡一卡二卡三精品| 韩国成人在线视频| 国产精品成人免费视频网站| bt自拍另类综合欧美| 成人国产午夜在线视频| 久久国产欧美日韩精品| 欧美在线暴力性xxxx| 国产av无码专区亚洲av毛片搜| 亚洲欧美自拍明星换脸| 国内精品伊人久久久久妇| 久久久久久曰本av免费免费| 欧美亚洲一区二区三区| 亚洲色偷偷色噜噜狠狠99| 精品久久久无码中文字幕| 国产一在线精品一区在线观看|